As part of Danaher Corporation, we’re proud to see this recognition in the 2025 Fierce Life Sciences Innovation Awards. The CRISPR therapy platform exemplifies how Danaher’s innovation ecosystem empowers life sciences researchers to push the boundaries of discovery and bring transformative therapies closer to patients. Congratulations to everyone contributing to meaningful progress in the life sciences!
We’re proud to be named a finalist in the 2025 Fierce Life Sciences Innovation Awards for accelerating the real-life impact of gene editing through a personalized #CRISPR therapy platform. This recognition reflects our commitment to solving the hardest problems together—helping innovators compress timelines, scale breakthroughs and improve lives. It’s an honor to be recognized alongside other trailblazers in #lifesciences. 🔗 https://lnkd.in/eAsmT6V2 #FierceLifeSciencesAwards #FierceInnovationAwards